Nuvectis Pharma, Inc.
NVCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875558
In the last 90 days, Nuvectis Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Nuvectis Pharma, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- 0 vs. Q3 2024
- Shares held
- 1.32M
- +271.4K (+25.9%) vs. Q3 2024
- Total value
- $7.15M
- +$546.0K (+8.3%) vs. Q3 2024
- New holders
- 7
- 14 more added
- Sold out
- 7
- 8 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $189.0M |
| Q1 2026 | 62 | $34.9M |
| Q4 2025 | 48 | $32.0M |
| Q3 2025 | 53 | $22.2M |
| Q2 2025 | 47 | $24.2M |
| Q1 2025 | 33 | $20.0M |
| Q4 2024 | 31 | $7.15M |
| Q3 2024 | 31 | $6.60M |
| Q2 2024 | 41 | $7.63M |
| Q1 2024 | 40 | $12.8M |
| Q4 2023 | 36 | $12.6M |
| Q3 2023 | 33 | $16.5M |
| Q2 2023 | 37 | $20.0M |
| Q1 2023 | 13 | $6.34M |
| Q4 2022 | 11 | $7.38M |
| Q3 2022 | 12 | $10.0M |
| Q2 2022 | 11 | $7.20M |
| Q1 2022 | 8 | $4.65M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Nuvectis Pharma, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baldwin Brothers Inc | 355,961 | $1.93M | 0.13% | +181,831+104.4% | Added |
| Vanguard Group Inc | 325,297 | $1.76M | 0.00% | +24,159+8.0% | Added |
| Marshall Wace, LLP | 124,571 | $673.9K | 0.00% | +81,757+191.0% | Added |
| Geode Capital Management, LLC | 79,243 | $428.8K | 0.00% | −473−0.6% | Reduced |
| BlackRock, Inc. | 62,342 | $337.3K | 0.00% | +12,788+25.8% | Added |
| Forbes J M & Co LLP | 59,000 | $319.2K | 0.03% | +10,599+21.9% | Added |
| Susquehanna International Group, LLP | 45,607 | $246.7K | 0.00% | +19,144+72.3% | Added |
| Gsa Capital Partners LLP | 34,751 | $188.0K | 0.01% | −15,378−30.7% | Reduced |
| Qube Research & Technologies Ltd | 30,594 | $165.5K | 0.00% | +8,161+36.4% | Added |
| Millennium Management LLC | 29,698 | $160.7K | 0.00% | −38,801−56.6% | Reduced |
| Northern Trust Corp | 25,725 | $139.2K | 0.00% | +10,472+68.7% | Added |
| Oppenheimer & Co Inc | 25,000 | $135.3K | 0.00% | +25,000 | New |
| State Street Corp | 22,000 | $119.0K | 0.00% | +6,700+43.8% | Added |
| Squarepoint Ops LLC | 19,071 | $103.2K | 0.00% | +19,071 | New |
| Two Sigma Investments, LP | 18,570 | $100.5K | 0.00% | −8,215−30.7% | Reduced |
| Edmond de Rothschild Holding S.A. | 15,170 | $82.1K | 0.00% | −4,000−20.9% | Reduced |
| Baxter Bros Inc | 15,000 | $81.2K | 0.01% | +2,500+20.0% | Added |
| Nations Financial Group Inc, | 13,500 | $73.0K | 0.01% | +3,500+35.0% | Added |
| Cubist Systematic Strategies, LLC | 6,294 | $34.1K | 0.00% | +6,294 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 4,479 | $24.2K | 0.01% | +4,479 | New |
| UBS Group AG | 2,669 | $14.4K | 0.00% | +2,658+24,163.6% | Added |
| Morgan Stanley | 2,319 | $12.5K | 0.00% | −29−1.2% | Reduced |
| Bank of America Corp | 1,615 | $8.74K | 0.00% | +855+112.5% | Added |
| Barclays PLC | 1,144 | $6.19K | 0.00% | 00.0% | Unchanged |
| Hollencrest Capital Management | 400 | $2.16K | 0.00% | +120+42.9% | Added |
| R Squared Ltd | 310 | $1.68K | 0.00% | +310 | New |
| JPMorgan Chase & Co | 179 | $968 | 0.00% | −13−6.8% | Reduced |
| BNP Paribas Arbitrage, SA | 115 | $622 | 0.00% | +115 | New |
| Steward Partners Investment Advisory, LLC | 100 | $541 | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 49 | $265 | 0.00% | +49 | New |
| NBC Securities, Inc. | 5 | $27 | 0.00% | −295−98.3% | Reduced |
| Iridian Asset Management LLC | 0 | $0 | 0.00% | −55,380−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −15,800−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −8,887−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −588−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −402−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |